Pathway to A Cure

Join our effort to detect myeloma sooner, customize treatment, conduct worldwide data analysis and clinical trials, and unlock the Pathway to A Cure.

Join the Conversation

Multiple myeloma is the second most common blood cancer. Yet the majority of patients have never heard of it until they are told they have the disease.

Make A Difference

Your donation today can make the difference for multiple myeloma patients in your community and around the world.

Black Swan Research Initiative Updates

  • Understanding the Nature of MRD-Positive Myeloma

    A study in the journal Blood reports for the first time the biological features of MRD (minimal

  • iStopMM (Iceland Screens Treats or Prevents Multiple Myeloma) really will stop myeloma for a whole country—Iceland!

    As announced this week, the IMF is funding the iStopMM (Iceland Screens Treats or Prevents

  • Black Swan Research Initiative: 2016 Perspectives from Researchers, Patients, Supporters

    The Black Swan Research Initiative is the IMF's groundbreaking and collaborative project aimed at

  • The Black Swan Research Initiative Is the “Myeloma Moonshot”

    Many of the approaches to curing cancer Vice President Joe Biden advocates as part of the

  • Black Swan Research Initiative Update – Nov. 17, 2015

    The Black Swan Research Initiative® (BSRI®), the International Myeloma Foundation’s innovative

    %d bloggers like this: